DeWorth Williams, of Williams Investment Company discusses BioForce Nanosciences
DeWorth Williams, of Williams Investment Company is pleased with the potential that new client BioForce Nanosciences has to offer. “They’ve been in business for about eight years and they have terrific technology,” said DeWorth Williams, “We’re very positive about it.”
According to the Williams Investment Company website, they are “engaged in the search for and evaluation of potential business opportunities” for acquisition and merging potential.
DeWorth Williams has been doing just that. “We’ve raised them 6 million dollars,” said Deworth Williams. “We took them from being a privately held company, to being public, they now have several hundred stockholders.”
BioForce produces nanotechnology, which DeWorth Williams sees as being the forefront of the technology market. “This is what the leading tech companies in the world are developing,” DeWorth Williams said, “We’ve long been aware that when it comes to technology, the smaller the better.” Deworth Williams continued to describe how small a nanometer really was, “a human hair,” said DeWorth Williams, “is 70,000 nanometers wide.”
BioForce produces the Nano eNabler, which DeWorth Williams describes as being the tool to teach people how to do nano science. According to BioForce’s website, they are the leading developer of ultra-miniaturized array technologies for solid-phase biomolecular analysis. Adding to this, DeWorth Williams said, “several of the leading universities in the nation are using these now, and the feedback we’re getting is terrific.”
The recent investment into BioForce Nanosciences is a positive move for Williams Investment Company, and one that DeWorth Williams sees as having unlimited potential.
- Contact Information
- Juha Julkunen
- Utah News Links
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.